TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$144,62
Dagwisseling
$147,53 - $153,49
Jaarwisseling
$87,20 - $183,00
Markkapitalisasie
20,08 mjd USD
Gemiddelde volume
1,58 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 476,06 m | 53,02% |
Bedryfskoste | 364,38 m | 49,09% |
Netto inkomste | -53,77 m | 31,09% |
Netto winsgrens | -11,29 | 54,98% |
Wins per aandeel | -0,41 | 35,94% |
EBITDA | -60,45 m | 24,46% |
Effektiewe belastingkoers | 2,46% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 968,28 m | 10,16% |
Totale bates | 1,66 mjd | 15,19% |
Totale aanspreeklikheid | 465,32 m | -31,20% |
Totale ekwiteit | 1,20 mjd | — |
Uitstaande aandele | 135,19 m | — |
Prys om te bespreek | 16,05 | — |
Opbrengs op bates | -9,95% | — |
Opbrengs op kapitaal | -11,83% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -53,77 m | 31,09% |
Kontant van bedrywe | 52,89 m | 191,81% |
Kontant van beleggings | -11,12 m | -146,05% |
Kontant van finansiering | 10,97 m | 60,32% |
Netto kontantverandering | 52,74 m | 298,17% |
Beskikbare kontantvloei | 54,04 m | 231,70% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
4 429
